ANTIBODY CAGE
Live / Applied — Suspended — suspension letter mailed (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 07 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99033222
- Mark type
- Stylized text
- Filed
- 07 Feb 2025
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for use in oncology, immunology, and pulmonology; Biological preparations, namely, custom engineered protein-antibody compounds for use in oncology, immunology, and pulmonology; Biologic compounds being a component of biological preparations for cancer, tumors, and respiratory diseases; Therapeutic agents for enhancing drug delivery, biodistribution, and cell target engagement
- Class 042 — Scientific and technological services: Design and development of biologics, proteins, protein therapeutics, protein design, and antibodies for medical and therapeutic uses; Laboratory services for biomanufacturing
Owner
- Archon Biosciences, Inc., Seattle, WA, US
Prosecution history
- 10 Feb 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 10 Feb 2026 — LETTER OF SUSPENSION E-MAILED
- 10 Feb 2026 — SUSPENSION LETTER WRITTEN
- 22 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION WRITTEN
- 17 Jul 2025 — ASSIGNED TO EXAMINER
- 07 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Feb 2025 — NEW APPLICATION ENTERED
- 22 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED